[Aging & Rejuvenation Science Series #2] GLP-1R Agonists May Mitigate Alzheimer’s via Energy Regulation: Insights from Nature Aging
In a May 2025 Nature Aging publication, Zhang and colleagues report that GLP-1 receptor agonists (GLP-1R agonists), widely used in the treatment of type 2 diabetes, may also alleviate Alzheimer’s disease (AD) symptoms in mice. Key Findin...
